Relationship of blood coagulation and fibrinolysis to vital exhaustion

Psychosomatic Medicine

Volumn 60, Issue 3, 1998, Pages 352-358

  Kop, Willem J ^a,b   Hamulyak, Karly ^b   Pernot, Carina ^b   Appels, Ad ^b  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Coagulation; Fibrinolysis; Hemostasis; Psychological stress; Vital exhaustion

Indexed keywords

BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; FIBRINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; CORONARY RISK; EXHAUSTION; FIBRINOLYSIS; HEMOSTASIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL STRESS; PHYSICAL STRESS; PRIORITY JOURNAL;

EID: 0031842990     PISSN: 00333174     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006842-199805000-00023     Document Type: Article

References (69)

1. Muller JE, Abela GS, Nesto RW, et al: Triggers, acute risk factors and vulnerable plaques: The lexicon of a new frontier. J Am Coll Cardiol 23:809-813, 1994
2. Fuster V, Badimon L, Badimon J, et al: The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 326:242-250, 310-318, 1992
3. Jern C, Erikson E, Tengborn L, et al: Changes of plasma coagulation and fibrinolysis in response to mental stress. Thromb Haemost 62:767-771, 1989
4. Cohen RJ, Epstein SE, Cohen LS, et al: Alternations of fibrinolysis and blood coagulation induced by exercise, and the role of beta-adrenergic-receptor stimulation. Lancet II:1264-1266, 1988
5. Patterson SM, Krantz DS, Gottdiener JS, et al: Prothrombotic effects of environmental stress: Changes in platelet function, hematocrit, and total plasma protein. Psychosom Med 57:592-599, 1995
6. Friedman M, Rosenman RH, Carroll V: Changes in serum cholesterol and blood clotting time in men subjected to cyclic variation of occupational stress. Circulation 17:852-861, 1958
7. Grignani G, Soffiantino F, Zucchella M, et al: Platelet activation by emotional stress in patients with coronary artery disease. Circulation 83(Suppl II):II128-136, 1991
8. Mittleman MA, Maclure M, Tofler GH, et al: Triggering of acute myocardial infarction by heavy exertion: Protection against triggering by regular exertion. N Engl J Med 329:1677-1683, 1993
9. Mittleman MA, Maclure M, Sherwood JB, et al: Triggering of acute myocardial infarction onset by episodes of anger. Circulation 92:1720-1725, 1995
10. Rozanski A, Bairey C, Krantz DS, et al: Mental stress and the induction of silent myocardial ischaemia in patients with coronary artery disease. N Engl J Med 318:1005-1012, 1988
11. Crisp A, Queenan M, D'Souza MF: Myocardial infarction and the emotional climate. Lancet 1:616-619, 1984
12. Rosengren A, Tibblin G, Wilhelmsen L: Self-perceived psychological stress and incidence of coronary artery disease in middle aged men. Am J Cardiol 68:1171-1175, 1991
13. Ruberman W, Weinblatt E, Goldberg J, et al: Psychosocial influences on mortality after myocardial infarction. N Engl J Med 311:552-559, 1984
14. Reed DM, LaCroix AZ, Karasek RA, et al: Occupational strain and the incidence of coronary heart disease. Am J Epidemiol 129:495-502, 1989
15. Selye H: The Stress of Life. New York, McGraw Hill, 1977
16. Falger PRJ, Schouten EGW: Exhaustion, psychological stressors in the work environment, and acute myocardial infarction in adult men. J Psychosom Res 36:777-786, 1992
17. Klaboe G, Otterstad JE, Winsness T, et al: Predictive value of prodromal symptoms in myocardial infarction. Acta Med Scand 222:27-30, 1987
18. Kuller L, Cooper M, Perper J: Epidemiology of sudden death. Arch Intern Med 129:714-719, 1972
19. Fraser GE: Sudden death in Auckland. Aust NZJ Med 8:490-499, 1978
20. Rissanen V, Romo M, Sittanen P: Premonitory symptoms and stress-factors preceding sudden death from ischemic heart disease. Acta Med Scand 20:389-396, 1978
21. Appels A: Mental precursors of myocardial infarction. Br J Psychiatry 156:465-471, 1990
22. Appels A, Mulder P: Excess fatigue as a precursor of myocardial infarction. Eur Heart J 9:758-764, 1988
23. Kop WJ, Appels A, Mendes de Leon CF, et al: Vital exhaustion predicts new cardiac events after successful coronary angioplasty. Psychosom Med 56:281-287, 1994
24. Lulofs R: Stress reactivity, Type A Behavior and Vital Exhaustion. Maastricht, Datawyse, 1990
25. Raikkönen K, Lassila R, Keltikangas-Jarvinen L, et al: Association of chronic stress with plasminogen activator inhibitor-1 in healthy middle-aged men. Arterioscler Thromb Vasc Biol 16: 363-367, 1996
26. Meade TW, Brozović M, Chakrabarti R, et al: Haemostatic function and ischemic heart disease; principal results of the Northwick Park Heart Study. Lancet 11:533-537, 1986
27. Kannel WB, Wolf PA, Castelli WP, et al: Fibrinogen and risk of cardiovascular disease; the Framingham study. J Am Med Assoc 258:1183-1186, 1987
28. Stone MC, Thorp JM: Plasma fibrinogen; a major coronary risk factor. J R Coll Gen Pract 35:565-569, 1985
29. Hamsten A, Walldius G, Szamosi A, et al: Plasminogen activator inhibitor in plasma; risk factor for recurrent myocardial infarction. Lancet II:3-9, 1987
30. Wilhelmsen L, Svärdsudd K, Korsan-Bengtsen K, et al: Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 311:501-505, 1984
31. Anzar J, Estellés A, Tormo G, et al: Plasminogen activator inhibitor activity and other fibrinolytic variables in patients with coronary artery disease. Br Heart J 59:535-541, 1988
32. Gunn CG, Hampton JW. CNS influence on plasma levels of factor VIII activity. Am J Physiol 12:124-30, 1967
33. Palmblad J, Blombäck M, Egberg N, et al: Experimentally induced stress in man; effects on blood coagulation and fibrinolysis. J Psychosom Res 21:87-92, 1977
34. Markowe HLJ, Marmot MG, Shipley MJ, et al. Fibrinogen; a possible link between social class and coronary heart disease. Br Med J 291:1312-1314, 1985
35. Møller L, Kristensen TS: Plasma fibrinogen and ischemic heart disease risk factors. Arterioscler Thromb 11:344-350, 1991
36. van Diest R, Appels A: Vital exhaustion and depression: A conceptual study. J Psychosom Res 35:535-544, 1991
37. Meesters C, Appels A: An interview to measure vital exhaustion I and II: Development and comparison with the Maastricht Questionnaire. Psychol Health 11:557-581, 1996
38. Tracy RP, Bovill EG: Hemostasis and risk of ischemic disease: Epidemiologic evidence with emphasis on the elderly. In Califf RM, Mark DB, Wagner GS (eds), Acute Coronary Care. 2nd Edition. St. Louis, Mosby, 1995, 27-43
39. Brozović M, Stirling Y, Harricks C, et al: Factor VII in an industrial population. Br J Haematol 28:381-391, 1974
40. Andreotti F, Davies GJ, Maseri A, et al: Fibrinolytic inhibition in blood; circadian fluctuation and possible relevance to coronary artery disease. In Predisposing Conditions for Acute Ischemic Syndromes. Maseri A, von Armin Th, eds. Garmisch-Partenkirchen, Steinkopf Verlag Darmstadt, October 14-15, 1988, 20-32
41. Appels A, Höppener P, Mulder P: A questionnaire to assess premonitory symptoms of myocardial infarction. Int J Cardiol 17:15-24, 1987
42. Kop WJ, Appels APWM, Mendes de Leon CF, et al: The effect of successful coronary angioplasty on feelings of exhaustion. Int J Cardiol 42:269-276, 1993
43. Kop WJ, Appels APWM, Mendes de Leon CF, et al: The relationship between severity of coronary artery disease and vital exhaustion. J Psychosom Res 40:397-405, 1996
44. Robins LN, Helzer JE, Ratcliff KS, et al: Validity of the Diagnostic Interview Schedule, version III; DSM-III diagnoses. Psychol Med 12:855-870, 1982
45. Bouman TK: The measurement of depression with questionnaires. PhD Thesis, Groningen, the Netherlands, 1987
46. Derogatis LR: SCL-90; Administration, Scoring, and Procedure Manual for the Revised Version. Baltimore, John Hopkins University, 1977
47. Arrindell WA, Ettema JHM: SCL-90; Handleiding bij een Mulltidimensionele Psychopathologie-Indicator. Lisse, Swets & Zeitlinger, 1986
48. Clauss A: Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol 17:237-246, 1957
49. Hoaglin DC, Mosteller F, Tukey JW: Understanding Robust and Exploratory Data Analysis. New York, John Wiley & Sons, 1983
50. Hultin MB: Fibrinogen and factor VII as risk factors in vascular disease. In Coller BS (ed), Progress in Haemostasis and Thrombosis, Vol 10. London, WB Saunders, 1991
51. Kluft C, Verheijen JH, Leiden Fibrinolysis Working Party: Blood collection and handling procedures for the assessment of tissue type plasminogen activator and plasminogen activator inhibitor 1. Fibrinolysis 4(Suppl 2):155-161, 1990
52. Ridker PM, Vaughan D, Stampfer MJ, et al: Endogenous tissue-type plasminogen activator and risk of myocardial infarction. Lancet 341:1165-1168, 1993
53. Munkvad S, Gram J, Jespersen J: A depression of active tissue plasminogen activator in plasma characterizes patients with unstable angina pectoris who develop myocardial infarction. Eur Heart J 11:525-528, 1990
54. Kirschstein W, Simianer S, Dempfle CE, et al: Impaired fibrinolytic capacity and tissue plasminogen activator release in patients with restenosis after percutaneous transluminal coronary angioplasty (PTCA). Thromb Haemost 62:772-775, 1989
55. Montalescot G, Ankri A, Vicaut E, et al: Fibrinogen after coronary angioplasty as a risk factor for restenosis. Circulation 92:31-38, 1995
56. Kop WJ: Vital exhaustion, cardiac events, and the relationship to depression. Eur Neuropsychopharmacol 5:220-221, 1995
57. Pietraszek MH, Takada Y, Nishimoto M, et al: Fibrinolytic activity in depression and neurosis. Thromb Res 63:661-666, 1991
58. Cannon WB, Mendenhall WL: Factors affecting the coagulation time of blood; VI the hastening of coagulation in pain and emotional excitement. Am J Physiol 34:251-261, 1914
59. Nicoloso G, Hauert J, Kruithof EK, et al: Fibrinolysis in normal subjects - Comparison between plasminogen activator inhibitor and other components of the fibrinolytic system. Thromb Haemost 59:299-303, 1988
60. Alessi MC, Juhan-Vague I, Declerck PJ, et al: Correlations between t-pa and pai-1 antigen and activity and t-pa/pai-1 complexes in plasma of control subjects and of patients with increased t-pa or pai-1 levels. Thromb Res 60:509-516, 1990
61. Juhan-Vague I, Pyke SD, Alessi MC, et al: Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. ECAT study group (European Concerted Action on Thrombosis and Disabilities). Circulation 94:2057-2063, 1996
62. Frasure-Smith N, Lesperance F, Talajic M: Depression and 18 month prognosis after myocardial infarction. Circulation 91: 999-1005, 1995
63. Wassertheil-Smoller S, Applegate WB, Berge K, et al, for the SHEP Cooperative Research Group: Change in depression as a precursor of cardiovascular events. Arch Intern Med 156:553-561, 1996
64. Keltikangas-Jarvinen L, Raikkönen K, Hautanen A, et al: Vital exhaustion, anger expression, and pituitary and adrenocortical hormones: Implications for the insulin resistance syndrome. Arterioscler Thromb Vasc Biol 16:275-280, 1996
65. Juhan-Vague I, Thompson SG, Jespersen J: Involvement of the hemostatic system in the insulin resistance syndrome. A study of 1500 patients with angina pectoris. The ECAT angina pectoris study group. Arterioscler Thromb 13:1865-1873, 1993
66. Stout RW: Insulin and atheroma. 20-yr perspective. Diabetes Care 13:631-654, 1990
67. van Doornen LJ, van Blokland RW: The relation of type a behavior and vital exhaustion with physiological reactions to real life stress. J Psychosom Res 33:715-725, 1989
68. Krantz DS, Kop WJ, Santiago HT, et al: Mental stress as a trigger of myocardial ischemia and infarction. Cardiol Clin 14:271-287, 1996
69. Kop WJ: Acute and chronic psychological risk factors for coronary syndromes: Moderating effects of coronary artery disease severity. J Psychosom Res 43:167-181, 1997